Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;22(2):182-190.
doi: 10.1111/1756-185X.13429. Epub 2018 Nov 8.

Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome

Affiliations

Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome

Jing Luo et al. Int J Rheum Dis. 2019 Feb.

Abstract

Objective: To investigate distinct features of renal involvement in patients with primary Sjögren's syndrome (pSS) and to identify potential factors associated with renal involvement.

Methods: Four hundred and thrity-four pSS patients from the Rheumatology Department of the First Affiliated Hospital of Wenzhou Medical University from 2013 to 2017 were included in a cross-sectional study. Patients with renal involvement were compared with their age- and gender-matched controls (pSS without renal involvement). Demographic, clinical, histological, nephritic, immunological features of renal involvement in pSS were systematically analyzed. Possible factors related to renal involvement were identified using multivariate logistic regression analyses.

Results: One hundred and ninety-two pSS patients (88.48%) with renal involvement were women with mean age of nearly 58 years and mean disease duration of above 4 years. Clinical manifestation, serologic and immunological features and renal biopsy class of the pSS patients with renal involvement were presented. By multivariate analyses, xerophthalmia, histological positivity for lower salivary gland biopsy (LSGB), anti-SSA/Ro52-positive, reduced complement 3 (C3) levels, hypoalbuminemia and anemia retained significant association with renal involvement in pSS (all P < 0.05).

Conclusion: In addition to LSGB pattern, anti-SSA/Ro52-positivity, reduced C3 levels, hypoalbuminemia and anemia, also indicate significant association with renal involvement in pSS. Therefore, early vigilance is required for patients with these clinical manifestations.

Keywords: Sjögren’s syndrome; cross-sectional studies; multivariate analyses; potential relevant factors; renal involvement.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Histologic evaluation of PASM‐stained renal biopsy specimens and H&E‐stained salivary gland biopsy specimens of primary Sjögren’s syndrome (pSS) patients with renal involvement. (A) pSS‐IgAN, MsPGN with FSGS, showing diffuse mesangial hyperplasia with focal interstitial lymphocytic infiltration (arrows) (PASM, 400×); (B) pSS‐cTIN with MsPGN and FSGS, showing diffuse interstitial lymphocytic and plasma infiltration with mild glomerular mesangial hyperplasia (PASM, 400×); (C) pSS‐cTIN, showing multifocal interstitial lymphocytic infiltration with fibrillation, tubular atrophy and protein cast (arrows; PASM, 400×); (D) pSS‐MN with aTIN, showing irregular thickenings out of the glomerular basement membrane as “spikes” with multifocal interstitial lymphocytic and plasma infiltration (arrows; PASM, 400×); (E) pSS‐MN, showing irregular thickenings out of the glomerular basement membrane as “spikes” and “chains” (arrows; PASM, 400×); (F) biopsy specimens from pSS patients with renal involvement showing significant perivascular and periductal lymphocytic infiltration with massive glandular atrophy (arrows; H&E, 200×). aTIN, acute tubulointerstitial nephritis; cTIN, clinical tubulointerstitial nephritis; FSGS, focal segmental glomerulosclerosis; H&E, hematoxylin and eosin‐stained; IgAN, IgA nephropathy; MN, membranous nephropathy; MsPGN, mesangial proliferative glomerulonephritis; PASM, periodic acid‐silver methenamine‐stained.

References

    1. Ramos‐Casals M, Solans R, Rosas J, et al. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87(4):210‐219. - PubMed
    1. Theander E, Jacobsson LT. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am. 2008;34(4):935‐947. - PubMed
    1. Ramos‐Casals M, Brito‐Zeron P, Siso‐Almirall A, Bosch X. Primary Sjogren syndrome. BMJ. 2012;344:e3821. - PubMed
    1. Sjögren H. Zur kenntnis der keratoconjunctivitis sicca II. Acta Ophthalmol. 2010;13(1‐2):1‐39. - PubMed
    1. Fox RI, Liu AY. Sjogren's syndrome in dermatology. Clin Dermatol. 2006;24(5):393‐413. - PubMed

MeSH terms